Okajima K, Inoue M, Morino Y, Itoh K
Eur J Biochem. 1984 Jul 16;142(2):281-6. doi: 10.1111/j.1432-1033.1984.tb08282.x.
Acetylation of cysteine S-conjugates of xenobiotics by microsomal N-acetyltransferase is the final step of detoxicative metabolism leading to mercapturic acid biosynthesis. To elucidate the subcellular site of N-acetylation and the effective mechanism by which the final metabolites are eliminated from the organisms, topological aspects and catalytic properties of microsomal N-acetyltransferase and mercapturic acid biosynthesis in vivo were investigated. Intravenous administration of radioactive S-benzyl-L-cysteine, a model compound of cysteine S-conjugates, resulted in rapid acetylation of the conjugate in liver and kidney to a similar extent. The acetylation was followed by a rapid excretion of the metabolite, a mercapturic acid, into the urine; about 60% of the injected dose appeared in urine within 60 min of administration. Limited proteolysis of microsomal vesicles obtained from liver and kidney by chymotrypsin or trypsin inactivated the transferase by 49-62% and 62-73%, respectively. Proteolytic inactivation of the transferase was not significantly affected by the presence of 0.04% sodium deoxycholate by which the vesicles became permeable to macromolecules due to its detergent action. To determine the sidedness of the active site of N-acetyltransferase on the microsomal membranes, two S-acetyldextran polymer derivatives (Mr 500 000) of cysteine and N-acetylcysteine which represent an nonpermeant substrate and product for this enzyme, respectively, were examined for their effects on the vesicle-associated enzyme activity. Both derivatives inhibited the transferase activity in a dose-dependent fashion; maximum inhibition of the enzyme activity was 40% by the former and 60% by the latter. Sulfobromophthalein strongly inhibited the enzyme activity and this inhibition was completely reversed by adding an equimolar amount of hepatic glutathione S-transferases (ligandins). In contrast to the strong inhibition by sulfobromophthalein itself, its glutathione S-conjugate did not inhibit the enzyme activity. These results indicate that the active site and the protease-sensitive domain(s) of the microsomal N-acetyltransferase are localized on the outer surface (cytoplasmic side) of endoplasmic reticulum and that the ligandin(s) might protect membranous N-acetyltransferase from inhibition by organic anions by binding them and catalyzing the conjugation with glutathione.
微粒体N - 乙酰转移酶将外源性物质的半胱氨酸S - 共轭物乙酰化是导致硫醚氨酸生物合成的解毒代谢的最后一步。为了阐明N - 乙酰化的亚细胞位点以及最终代谢产物从生物体中消除的有效机制,研究了微粒体N - 乙酰转移酶的拓扑结构和催化特性以及体内硫醚氨酸的生物合成。静脉注射放射性S - 苄基 - L - 半胱氨酸(一种半胱氨酸S - 共轭物的模型化合物)导致肝脏和肾脏中该共轭物的快速乙酰化,程度相似。乙酰化之后,代谢产物硫醚氨酸迅速排泄到尿液中;给药后60分钟内,约60%的注射剂量出现在尿液中。用胰凝乳蛋白酶或胰蛋白酶对从肝脏和肾脏获得的微粒体囊泡进行有限的蛋白水解,分别使转移酶失活49 - 62%和62 - 73%。转移酶的蛋白水解失活不受0.04%脱氧胆酸钠的显著影响,由于其去污剂作用,囊泡对大分子变得通透。为了确定微粒体膜上N - 乙酰转移酶活性位点的方向性,研究了两种半胱氨酸和N - 乙酰半胱氨酸的S - 乙酰葡聚糖聚合物衍生物(分子量500 000),它们分别代表该酶的非通透底物和产物,对囊泡相关酶活性的影响。两种衍生物均以剂量依赖性方式抑制转移酶活性;前者对酶活性的最大抑制率为40%,后者为60%。磺溴酞强烈抑制酶活性,加入等摩尔量的肝脏谷胱甘肽S - 转移酶(配体蛋白)可完全逆转这种抑制。与磺溴酞本身的强烈抑制相反,其谷胱甘肽S - 共轭物不抑制酶活性。这些结果表明,微粒体N - 乙酰转移酶的活性位点和蛋白酶敏感结构域位于内质网的外表面(细胞质侧),并且配体蛋白可能通过结合有机阴离子并催化其与谷胱甘肽的共轭作用来保护膜结合的N - 乙酰转移酶免受抑制。